Transwell assay indicated that overexpression of SMAD2 promoted and knockdown of SMAD2 inhibited migration and invasion in HCC cells (Fig. 2c and Supplementary Figure 3B). The gene discussed is SMAD2; the disease is hepatocellular carcinoma.